BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Henry Schein, Inc. (HSIC) Names Carolynne Borders Vice President of Investor Relations


11/28/2012 8:41:11 AM

MELVILLE, N.Y., Nov. 28, 2012 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, medical and animal practitioners, today announced that it has appointed Carolynne Borders as Vice President of Investor Relations. In this role, Carolynne will be responsible for driving Henry Schein's strategic communications with institutional investors and the securities analyst community.

"Carolynne brings a strong track record in the development and execution of results-driven investor relations programs," said Steven Paladino, Executive Vice President and Chief Financial Officer. "Over her career, Carolynne has built a valuable network of relationships with the financial community as well as an expertise in institutional targeting, strategic acquisition communications and enhancing corporate reputation. We are pleased to have her join the Henry Schein team as we execute on our global strategy to deliver value to investors, Team Schein Members and other key stakeholders."

Ms. Borders joins Henry Schein with approximately twenty years of experience as an investor relations professional. Most recently, she served as Vice President, Investor Relations & Corporate Communications at a global designer of semiconductor products. Earlier, she held a similar role at a leading manufacturer of digital audio products. She has served as a Senior Associate at The Financial Relations Board, one of the largest investor relations agencies at the time, representing the firm's technology clientele. Ms. Borders was also co-founder and executive vice president of LI Invest, a former not-for-profit organization that promoted investment in public and private companies in the Long Island region. Carolynne earned a Bachelor of Science Degree in Business from Marist College.

About Henry Schein, Inc.

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs more than 15,000 Team Schein Members and serves approximately 775,000 customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries. The Company's sales reached a record $8.5 billion in 2011, and have grown at a compound annual rate of 18 percent since Henry Schein became a public company in 1995. For more information, visit the Henry Schein Web site at www.henryschein.com.

SOURCE Henry Schein, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES